These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3766908)

  • 1. Clinical and in vitro antiproliferative properties of recombinant DNA-derived human interferon-alpha 2.
    Freedman MH; Estrov Z; Williams BR; Gelfand EW
    Am J Pediatr Hematol Oncol; 1986; 8(3):178-82. PubMed ID: 3766908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies.
    Freedman MH; Fish E; Estrov Z; Grunberger T; Williams BR
    Exp Hematol; 1985 Oct; 13(9):932-6. PubMed ID: 3862600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alpha interferon on growth of leukemic and normal hematopoietic progenitors. Synergism with H2 histamine receptor antagonists.
    Douer D; Kneller A; Ben-Bassat I; Chitayat SD; Shaked N; Salzberg S; Ramot B
    Exp Hematol; 1989 Jun; 17(5):443-8. PubMed ID: 2714424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
    Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
    Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
    Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
    J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
    Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
    J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
    Fish EN; Banerjee K
    Prog Clin Biol Res; 1985; 202():385-90. PubMed ID: 3008171
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
    Justesen J; Berg K
    J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
    Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
    Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha A interferon.
    Gallagher RE; Lurie KJ; Leavitt RD; Wiernik PH
    Leuk Res; 1987; 11(7):609-19. PubMed ID: 3475513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
    Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
    Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy.
    Fabian I; Kravtsov V; Elis A; Gurevitch O; Ackerstein A; Slavin S; Nagler A
    Leukemia; 1994 Aug; 8(8):1379-84. PubMed ID: 8057677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha.
    Michalevicz R; Aderka D; Frisch B; Revel M
    Leuk Res; 1988; 12(10):845-51. PubMed ID: 3199843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
    Estrov Z; Freedman MH
    Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.